mani
report
suggest
patient
hyperuricemia
risk
cardiovascular
diseas
hypertens
chronic
kidney
diseas
inde
report
demonstr
contribut
uric
acid
endotheli
cell
dysfunct
howev
uric
acid
antioxid
activ
hypouricemia
decreas
renal
hemodynam
low
serum
uric
acid
level
neg
affect
cardiovascular
system
hand
sever
recent
report
suggest
xo
act
inflamm
activ
endotheli
cell
macrophag
xo
shown
induc
interleukin
il
secret
via
inflammasom
activ
macrophag
angiotensin
ii
ang
ii
shown
induc
xo
express
endotheli
cell
macrophag
thu
base
report
benefici
effect
xo
inhibitor
feb
cardiovascular
event
xo
inhibitor
may
benefici
effect
independ
level
uric
acid
studi
use
mous
model
hypertens
induc
ang
ii
character
aortic
fibrosi
macrophag
accumul
investig
effect
xo
inhibitor
feb
pathogenesi
vascular
remodel
independ
level
uric
acid
found
feb
benefici
effect
vascular
fibrosi
hypertens
accumul
macrophag
aorta
follow
ang
ii
administr
express
high
level
xo
major
target
cell
feb
may
macrophag
result
suggest
feb
inhibit
ang
iiinduc
transform
growth
factor
tgf
express
macrophag
suppress
fibrot
process
aorta
feb
may
potenti
effect
hypertens
accompani
aortic
stiff
clinic
practic
via
addit
effect
outsid
amelior
hyperuricemia
detail
materi
method
section
onlineonli
supplementari
data
studi
carri
accord
recommend
guidelin
anim
experiment
administ
tokushima
univers
anim
care
use
committe
tokushima
univers
protocol
approv
anim
care
use
committe
tokushima
univers
male
mice
week
old
purchas
clea
japan
tokyo
japan
anim
hous
temperaturecontrol
room
lightdark
cycl
free
access
food
water
ang
ii
sigmaaldrich
dissolv
normal
salin
continu
infus
mgkgd
week
subcutan
implant
osmot
minipump
alzet
model
alza
mountain
view
ca
dose
use
studi
base
result
anoth
studi
induc
vascular
remodel
blood
pressur
elev
mice
without
ang
ii
administr
shamoper
skin
incis
feb
tokyo
chemic
industri
tokyo
japan
mgkgday
po
suspend
carboxymethylcellulosenorm
salin
administ
everi
day
ang
ii
infus
mice
divid
group
control
ang
ii
feb
ang
ii
feb
n
systol
blood
pressur
measur
noninvas
computer
tailcuff
system
softron
tokyo
japan
n
two
week
ang
ii
infus
mice
anesthet
intraperiton
inject
pentobarbit
sodium
somnopentyl
kyoritsu
seiyaku
tokyo
japan
dosag
mgkg
xylazin
selactar
bayer
osaka
japan
dosag
mgkg
lidocain
hydrochlorid
xylocain
astrazeneca
london
uk
inject
subcutan
local
analgesia
absenc
pedal
withdraw
reflex
check
frequent
ensur
adequaci
anesthesia
anesthet
inject
mice
exhibit
sign
pain
surgeri
aorta
isol
analysi
end
experi
qrtpcr
histomorpholog
immunofluoresc
blood
sampl
incub
minut
centrifug
rpm
minut
supernat
serum
use
measur
xo
activ
uric
acid
rat
aortic
smooth
muscl
cell
isol
previous
describ
mous
embryon
fibroblast
isol
previous
describ
check
almost
isol
cell
fibroblast
immunofluoresc
fibroblastspecif
protein
fsp
antibodi
rat
aortic
smooth
muscl
cell
mous
embryon
fibroblast
cultur
dmem
nacalai
tesqu
kyoto
japan
mous
macrophag
cell
purchas
atcc
manassa
va
cultur
nacalai
tesqu
cell
maintain
humidifi
atmospher
co
air
feb
nm
ad
hour
prior
ang
ii
stimul
western
blot
mtt
assay
cultur
medium
chang
serumfre
medium
day
stimul
test
normal
equal
varianc
parametr
data
analysi
data
present
mean
sem
statist
signific
assess
analysi
varianc
follow
bonferroni
posthoc
test
multipl
comparison
valu
p
p
consid
signific
number
individu
experi
indic
n
gene
express
analysi
genevestig
mannwhitney
utest
use
statist
analysi
ang
ii
administr
affect
serum
xo
activ
serum
uric
acid
level
feb
administr
suppress
serum
xo
activ
serum
uric
acid
level
shamoper
well
ang
iiinfus
mice
figur
supplementari
figur
confirm
feb
treatment
produc
pharmacolog
effect
mice
irrespect
ang
ii
infus
feb
affect
ang
iiinduc
heart
weight
increas
figur
suppress
ang
iiinduc
systol
blood
pressur
elev
figur
elastica
van
gieson
stain
show
feb
suppress
ang
iiinduc
aortic
perivascular
fibrosi
redstain
area
medial
thicken
mice
figur
result
suggest
suppress
effect
feb
ang
iiinduc
aortic
fibrosi
blood
pressur
elev
independ
circul
uric
acid
level
sinc
smooth
muscl
cell
prolifer
link
medial
thicken
aorta
also
assess
effect
feb
aortic
smooth
muscl
cell
vitro
supplementari
figur
feb
affect
ang
iiinduc
vsmc
prolifer
figur
effect
feb
ang
iiinduc
aortic
fibrosi
medial
thicken
feb
administr
mgkgday
week
significantli
suppress
serum
xo
activ
mice
statist
signific
assess
anova
multipl
comparison
made
bonferroni
ttest
mean
sem
p
vs
vehicl
administr
n
b
feb
affect
ang
iiinduc
heart
weight
elev
adjust
bodi
weight
statist
signific
assess
anova
multipl
comparison
made
bonferroni
ttest
mean
sem
p
vs
without
ang
ii
n
c
feb
suppress
ang
iiinduc
systol
blood
pressur
elev
statist
signific
assess
anova
multipl
comparison
made
bonferroni
ttest
mean
sem
p
vs
without
ang
ii
p
vs
ang
ii
alon
n
evg
stain
show
feb
suppress
ang
iiinduc
aortic
fibrosi
stain
red
ang
iiinduc
medial
thicken
scale
bar
mm
e
four
graph
indic
medial
layer
fibrot
layer
medial
layer
diamet
fibrot
layer
diamet
statist
signific
assess
anova
multipl
comparison
made
bonferroni
ttest
mean
sem
p
p
n
abbrevi
ang
ii
angiotensin
ii
anova
analysi
varianc
evg
elastica
van
gieson
feb
febuxostat
xo
xanthin
oxidas
addit
feb
affect
ang
iiinduc
akt
phosphoryl
rat
aortic
smooth
muscl
cell
supplementari
figur
c
result
agre
well
effect
feb
ang
iiinduc
medial
thicken
determin
feb
suppress
ang
iiinduc
aortic
fibrosi
examin
inflamm
aorta
immunofluoresc
stain
show
ang
ii
induc
macrophag
accumul
aorta
wherea
attenu
feb
treatment
figur
mrna
express
also
induc
aorta
mice
treat
ang
ii
alon
mice
treat
ang
ii
feb
figur
mrna
express
level
monocyt
chemotact
protein
mcp
lysozym
lysm
increas
aorta
ang
ii
alon
group
ang
ii
feb
group
figur
result
suggest
feb
administr
ang
ii
induc
inflamm
aorta
determin
target
cell
feb
use
xo
immunofluoresc
stain
aorta
section
mice
treat
ang
ii
result
indic
cell
highli
express
xo
scatter
adventitia
medial
area
endothelium
low
level
xo
express
figur
supplementari
figur
xoexpress
cell
coloc
figur
fibroblastspecif
protein
fsp
supplementari
figur
result
suggest
xo
highli
express
macrophag
feb
mainli
modul
function
macrophag
accumul
aorta
upon
ang
ii
infus
result
suggest
feb
mainli
affect
accumul
macrophag
use
macrophag
cell
vitro
system
feb
reduc
ang
iiinduc
xo
activ
cell
figur
examin
effect
ang
ii
feb
xo
express
similar
previou
result
found
ang
ii
induc
xo
express
figur
howev
presenc
feb
ang
ii
induc
xo
express
figur
fibrot
process
macrophagederiv
play
key
role
fibroblast
differenti
myofibroblast
extracellular
matrix
product
fibroblast
myofibroblast
feb
significantli
suppress
ang
iiinduc
mrna
express
macrophag
figur
moreov
aortic
tissu
found
ang
ii
administr
induc
mrna
express
feb
administr
figur
fibroblast
differenti
myofibroblast
express
muscl
actin
key
factor
fibrot
process
macrophagederiv
primari
factor
induc
differenti
assess
differenti
use
doubl
immunofluoresc
stain
aorta
antibodi
fibroblast
marker
antibodi
usual
express
medial
area
howev
ang
ii
alon
group
cell
also
scatter
around
outer
side
medial
area
figur
cell
found
outer
side
medial
area
ang
ii
group
ang
ii
feb
group
figur
ang
ii
alon
group
sever
cell
fibroblast
posit
almost
cell
neg
ang
ii
feb
group
figur
thu
feb
reduc
number
fibroblast
induc
ang
ii
outer
side
medial
area
result
agre
well
hour
induc
mrna
express
presenc
feb
nm
statist
signific
assess
anova
multipl
comparison
made
bonferroni
ttest
mean
sem
p
n
b
mrna
express
induc
ang
ii
feb
administr
aorta
statist
signific
assess
anova
multipl
comparison
made
bonferroni
ttest
mean
sem
p
n
c
ang
ii
administr
cell
fibroblast
locat
fibrot
area
ang
ii
alon
group
sever
fibroblast
posit
white
arrowhead
almost
fibroblast
neg
ang
ii
feb
group
scale
bar
abbrevi
muscl
actin
adv
adventitia
ang
ii
angiotensin
ii
anova
analysi
varianc
feb
febuxostat
media
tgf
transform
growth
factor
result
indic
suppress
effect
feb
ang
iiinduc
macrophagederiv
mrna
express
also
examin
effect
feb
fibroblast
use
mous
embryon
fibroblast
vitro
system
found
ang
ii
induc
mrna
express
fibroblast
feb
alter
effect
supplementari
figur
also
found
ang
ii
slightli
induc
fibroblast
prolifer
feb
affect
supplementari
figur
result
suggest
macrophagederiv
express
key
factor
fibrot
process
feb
suppress
ang
iiinduc
macrophagederiv
express
major
find
studi
xo
inhibitor
feb
suppress
ang
iiinduc
vascular
fibrosi
affect
mainli
accumul
macrophag
adventitia
also
found
inhibit
xo
feb
macrophag
suppress
ang
iiinduc
express
link
promot
fibroblast
differenti
myofibroblast
fibrot
process
find
serum
uric
acid
chang
mous
model
ang
iiinduc
vascular
remodel
use
studi
effect
feb
like
independ
uric
acid
present
studi
feb
suppress
ang
iiinduc
hypertens
although
affect
ang
iiinduc
heart
weight
elev
previou
studi
report
lysmposit
monocyt
mediat
ang
iiinduc
hypertens
lysm
mrna
express
result
aorta
agre
well
report
sever
studi
suggest
benefici
effect
feb
xo
inhibitor
endotheli
function
hypertens
landmess
et
al
demonstr
ang
ii
induc
reactiv
oxygen
speci
ro
product
part
via
xo
activ
endotheli
cell
therefor
feb
might
protect
effect
part
endotheli
cell
addit
macrophag
appear
major
target
feb
present
studi
discrep
effect
feb
hypertens
heart
weight
suggest
feb
affect
ang
ii
signal
transduct
lead
cardiomyocyt
hypertrophi
data
suggest
feb
littl
effect
smc
line
low
express
xo
aortic
media
regardless
ang
ii
infus
clarifi
mechan
feb
suppress
ang
iiinduc
aortic
fibrosi
evalu
macrophag
accumul
immunofluoresc
stain
mrna
express
aorta
show
feb
administr
ang
ii
induc
much
macrophag
accumul
mrna
express
level
inflammatori
cytokin
result
may
partli
explain
suppress
effect
feb
fibrosi
tissu
fibrot
process
macrophagederiv
product
play
key
role
extracellular
matrix
product
fibroblast
myofibroblast
fibroblast
differenti
myofibroblast
produc
extracellular
matrix
normal
fibroblast
myofibroblast
activ
fibroblast
express
wherea
normal
one
elucid
target
feb
xo
highli
express
accumul
macrophag
aorta
feb
significantli
suppress
ang
iiinduc
express
macrophag
report
suggest
ro
induc
express
preliminari
data
suggest
feb
inhibit
ang
iiinduc
ro
product
aorta
supplementari
figur
thu
feb
might
suppress
ang
iiinduc
express
part
via
suppress
ro
product
addit
reduc
xo
activ
feb
suppress
xo
express
induc
ang
ii
macrophag
cell
landmess
et
al
demonstr
ang
ii
induc
xo
express
via
redoxsensit
pathway
involv
nicotinamid
adenin
dinucleotid
phosphat
nadph
oxidas
yisireyili
et
al
also
demonstr
feb
suppress
express
level
nadph
oxidas
subunit
thu
feb
might
also
suppress
express
xo
part
via
affect
nadph
oxidas
present
studi
conclud
feb
suppress
ang
iiinduc
vascular
fibrosi
via
mainli
inhibit
express
accumul
macrophag
adventitia
addit
effect
outsid
amelior
hyperuricemia
result
suggest
possibl
ang
signal
axi
exist
macrophag
addit
ive
et
al
demonstr
xo
induc
product
via
mitochondri
ro
gener
macrophag
show
feb
administr
ang
ii
induc
express
aorta
thu
ro
might
involv
mediat
xo
effect
feb
frequent
use
patient
hyperuricemia
accompani
metabol
syndrom
addit
effect
feb
use
suppress
cardiovascular
event
patient
hyperuricemia
supplementari
data
avail
american
journal
hypertens
onlin
